RxDoctor Payments Data

Sanjay Iyer, MD

Emergency Medicine · Charlotte, NCNPI 1942469580

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $15,250 of the $17,768 with a category attached, or 85.8%. MDD US Operations, LLC accounts for 86.7% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $7,874 and has fallen 96.5% since, to $272 in 2025. Among emergency medicine clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,768in general payments, 2019–2025

Across 36 payments — averaging $493.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • MDD US Operations, LLC$15K
  • Murata Vios, Inc.$2K
  • Stryker$178
  • Neurocrine Biosciences, Inc.$76
  • Pfizer$72
  • Adamas Pharmaceuticals, Inc.$58
  • plus $194 from 6 others

What the payments were for

  • Consulting fees$1,78810%
  • Speaking & faculty fees$15,25086%
  • Travel & lodging$1171%
  • Food & beverage$6143%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,768 in reported general payments places this provider in the 95th percentile of 1,657 emergency medicine providers in North Carolina.

See all emergency medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$58,155
Medicare patients
424
Services billed
727

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Primidone12$241
Tamsulosin Hcl15$162
Bupropion XlBupropion Hcl15$158
Famotidine25$145
Quetiapine Fumarate28$134
Pantoprazole Sodium21$101
Levothyroxine Sodium13$95
Omeprazole13$86
Ibuprofen25$76
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$53
Ciprofloxacin Hcl15$53
Lorazepam16$48
Furosemide11$29
Carvedilol15$27

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Amneal Pharmaceuticals LLCLevothyroxine Sodium$56$9513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,657 emergency medicine providers in North Carolina.

Other emergency medicine in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →